- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
South Korean Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
5
High return on equity, past performance and sound balance sheet.
5 companies
SK Biopharmaceuticals
Market Cap: ₩10.4t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩133,200.00
7D
-0.6%
1Y
25.8%
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩394,000.00
7D
-1.9%
1Y
60.8%
DreamCIS
Market Cap: ₩141.6b
Provides clinical research services in South Korea.
A223250
₩5,950.00
7D
20.7%
1Y
96.7%
JW Shinyak
Market Cap: ₩79.8b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,500.00
7D
2.7%
1Y
-0.6%
JW Lifescience
Market Cap: ₩216.3b
Provides national infusion solutions in South Korea and internationally.
A234080
₩13,970.00
7D
2.3%
1Y
23.6%